Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Harewood L, Robinson H, Harris R, Jabbar Al-Obaidi MS, Jalali GR, Martineau M et al. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia 2003; 17: 547–553.

    Article  CAS  Google Scholar 

  2. Jabbar Al-Obaidi MS, Martineau M, Bennett CF, Franklin IM, Goldstone AH, Harewood L et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 2002; 16: 669–674.

    Article  Google Scholar 

  3. Mikhail FM, Serry KA, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM et al. AML1 gene over-expression in childhood acute lymphoblastic leukemia. Leukemia 2002; 16: 658–668.

    Article  CAS  Google Scholar 

  4. Morel F, Herry A, Le Bris M-J, Douet-Guilbert N, Le Calvez G, Marion V et al. AML1 amplification in a case of childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 2002; 137: 142–145.

    Article  CAS  Google Scholar 

  5. Alvarez Y, Coll MD, Bastida P, Ortega JJ, Caballin MR . AML1 amplification in a child with acute lymphoblastic leukemia. Cancer Genet Cytogenet 2003; 140: 58–61.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the Leukaemia Research Fund for financial support; Dr Anne Hagermeijer (EU Concerted Action) and Dr Roland Berger (Paris) for cosmids ICRF c103C0664 and H11086, respectively; Dr John Crolla and his team, Wessex Regional Genetics Laboratory, Salisbury, for growing and preparation of the AML1-specific cosmids; the Clinical Trial Service Unit (CTSU), Oxford, for clinical and survival data. We are grateful to the following UKCCG cytogenetic laboratories for providing cytogenetic and FISH data as well as fixed cell suspensions: West Midlands Regional Genetics Services, Birmingham Women's Hospital; Haematology Cytogenetics Laboratory, University Hospital of Wales, Cardiff; SE Scotland Cytogenetics Services, Western General Hospital, Edinburgh; LRF Centre for Childhood Leukemia, Great Ormond Street Hospital, London; Cytogenetics Department, St James Hospital, Leeds; Merseyside & Cheshire Genetics Laboratory, Liverpool Women's Hospital, Liverpool; Oncology Cytogenetics Service, Christie Hospital, Manchester; North Trent Cytogenetics Service, Sheffield Children's Hospital NHS Trust, Sheffield.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robinson, H., Broadfield, Z., Cheung, K. et al. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia 17, 2249–2250 (2003). https://doi.org/10.1038/sj.leu.2403140

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403140

This article is cited by

Search

Quick links